Prognostic Impact of Port-Site Metastasis After Diagnostic Laparoscopy for Epithelial Ovarian Cancer

Ann Surg Oncol. 2016 Dec;23(Suppl 5):834-840. doi: 10.1245/s10434-016-5415-9. Epub 2016 Jul 12.

Abstract

Background: This study was designed to evaluate the prevalence, morbidity, and prognostic impact of port-site metastasis (PSM) in patients with epithelial ovarian cancer (EOC) undergoing laparoscopy before subsequent primary debulking surgery (PDS).

Methods: All consecutive patients treated between 2000 and 2014, who had a laparoscopy followed by PDS, were extracted from our prospectively maintained database. All patients with histological examination of port-sites were included in this unicentric exploratory analysis.

Results: A total of 250 (25.5 %) of 982 patients with EOC underwent laparoscopy before PDS. Port-site resection was performed in those 214 (85.6 %) patients in whom a complete or almost complete resection with residuals ≤1 cm was achieved. Median interval between laparoscopy and PDS was 25 days. PSM was detected in 100 of 214 patients (46.7 %). Risk factors for PSM were higher tumor stage (odds ratio [OR] 13.5, 95 % confidence interval [CI] 2.9-62.0, p = 0.04), positive lymph node status (OR 3.0, 95 % CI 1.3-6.7, p = 0.009), and ascites >500 mL (OR 3.9, 95 % CI 1.5-10.0, p = 0.005). Wound healing disorders and postoperative morbidity were significantly higher in patients with PSM (Clavien-Dindo Classification grade 3-5: 41.0 vs. 14.9 %, p < 0.001). However, multivariate Cox-regression models did not identify PSM as independent prognostic factor.

Conclusions: The prevalence of PSM after laparoscopy in EOC patients is considerably high. PSM had no impact on survival; however, PSM were associated with more postoperative complications and a higher surgical treatment burden. This should be balanced with the expected benefit when laparoscopy is considered for the management of EOC.

MeSH terms

  • Aged
  • Ascites / complications
  • Cytoreduction Surgical Procedures
  • Female
  • Humans
  • Laparoscopy / adverse effects*
  • Lymphatic Metastasis
  • Middle Aged
  • Neoplasm Seeding*
  • Neoplasm Staging
  • Neoplasm, Residual
  • Neoplasms, Glandular and Epithelial / secondary*
  • Neoplasms, Glandular and Epithelial / surgery*
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / surgery*
  • Pleural Effusion, Malignant / etiology
  • Risk Factors
  • Surgical Wound / etiology
  • Surgical Wound / pathology*
  • Surgical Wound / surgery
  • Survival Rate
  • Wound Healing